Document is current
Any future updates will be listed below
-
Authors
Konishi, Hiroaki
Saito, Takeshi
Takahashi, Shuichiro
Tanaka, Hiroki
Okuda, Katsuhiro
Akutsu, Hiroaki
Dokoshi, Tatsuya
Sakatani, Aki
Takahashi, Keitaro
Ando, Katsuyoshi
Kashima, Shin
Ueno, Nobuhiro
Moriichi, Kentaro
Ogawa, Naoki
Fujiya, Mikihiro
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (21KK0291, 22K08047, 21K07929)
Hirose Foundation
Intractable Disease Health and Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare
- License Information
-
More Information
Article History
Received: 31 December 2024
Accepted: 2 April 2025
First Online: 7 April 2025
Declarations
:
: Hiroaki Konishi and Mikihiro Fujiya report that Kamui Pharma Inc. provides financial support. They are part of a joint research department funded by Kamui Pharma Inc. Other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
: All experiments were performed according to the Guidelines of the Public Health Service Policy on the Humane Use and Care of Laboratory Animals. The study received ethical approval for using an opt-out methodology from the Medical Ethics Committee of Asahikawa Medical University (Approval No. R6-005). All animal experiments were reported in accordance with the ARRIVE guidelines.
